Online citations, reference lists, and bibliographies.
← Back to Search

Double‐blind Study Of Cyamemazine And Diazepam In The Alcohol Withdrawal Syndrome

J. Favre, H. Allain, H. Aubin, Elisabeth Frija-Orvoen, C. Gillet, M. Lejoyeux, A. Payen, Michel Weber, S. Garcia-Acosta, Imane Kermadi, M. Dib
Published 2005 · Medicine, Psychology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Cyamemazine is an original phenothiazine derivative which showed similar efficacy and tolerability to lorazepam during ethanol withdrawal in mice. This study investigated cyamemazine for its efficacy and tolerability in alcohol‐dependent patients electing an alcohol withdrawal procedure, in comparison with diazepam.
This paper references
10.1176/AJP.125.12.1640
Treatment of the acute alcohol withdrawal state: a comparison of four drugs.
S. C. Kaim (1969)
10.3109/15563657608988141
Enhancement of alcohol withdrawal convulsions in mice by haloperidol.
K. Blum (1976)
10.1097/00004714-198111000-00006
Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care.
J. Shaw (1981)
10.1038/clpt.1982.105
Nonfatty acid–modulated variations in drug binding due to heparin
C. Naranjo (1982)
10.1038/clpt.1983.256
Diazepam loading: Simplified treatment of alcohol withdrawal
E. Sellers (1983)
10.1111/J.1360-0443.1989.TB00737.X
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).
J. Sullivan (1989)
10.1192/BJP.157.4.491
Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal.
P. Glue (1990)
10.2165/00003495-199447060-00009
Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.
D. Peters (1994)
10.1111/J.1530-0277.1994.TB00053.X
Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.
B. Adinoff (1994)
10.1016/0091-3057(94)90251-8
Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats
I. Uzbay (1994)
10.1176/AJP.152.1.1
Grief: normal and pathological variants.
M. Viederman (1995)
10.1016/S0025-7125(05)70554-X
Pharmacotherapies for alcohol abuse. Withdrawal and treatment.
R. Saitz (1997)
10.1016/S0028-3908(97)00134-2
Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons
D. Salgado-Commissariat (1997)
10.1007/s002130050785
Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice
M. Naassila (1998)
10.1016/S0278-5846(98)00060-8
Pharmacological treatment of alcoholism
M. B. Gatch (1998)
10.1016/S0188-0128(98)00013-X
Ethanol, GABA and epilepsy.
S. Brailowsky (1999)
10.1615/CRITREVNEUROBIOL.V13.I4.10
A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders.
P. Jobe (1999)
10.1016/S0278-5846(00)00133-0
Monoaminergic changes associated with audiogenic seizures in ethanol-dependent rats
L. Yu (2000)
10.1007/s002130050010
5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity
M. Alvarez-Guerra (2000)
10.1016/S0924-9338(00)00526-5
The preclinical pharmacologic profile of tiapride
B. Scatton (2001)
10.1016/S0166-4328(01)00238-8
Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice
M. Bourin (2001)
10.1016/S0014-2999(02)02489-5
5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle.
M. Alvarez-Guerra (2002)
10.1007/s00221-002-1259-6
Comparison of the effects of 5-HT1A and 5-HT4 receptor activation on field potentials and epileptiform activity in rat hippocampus
K. Tokarski (2002)
10.1056/NEJMRA020617
Management of drug and alcohol withdrawal.
T. Kosten (2003)
10.1007/s00210-002-0665-4
Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine
J. Peinado (2003)
10.1016/S0006-2952(02)01515-0
Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.
A. Hameg (2003)
10.1016/S0149-7634(03)00030-7
Alcohol and withdrawal: from animal research to clinical issues
P. Witte (2003)
10.1111/J.1527-3458.2004.TB00023.X
Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome.
M. Bourin (2004)
10.1007/s00213-005-2172-z
A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)
Y. Hodé (2005)



This paper is referenced by
10.1016/j.ica.2020.119956
An overview on the progress and development on the palladium catalyzed direct cyanation
S. Heydari (2021)
10.1093/alcalc/agaa125
The Effectiveness of Non-Benzodiazepine, Non-Barbiturate Medications for Alcohol Withdrawal Syndrome: A Rapid Systematic Review.
Abhishek Ghosh (2020)
10.1556/650.2019.31424
Első lépés egy egységes szemlélet felé: az Alkohol Megvonási Skála bevezetése a hazai betegellátási gyakorlatba
Bence András Lázár (2019)
10.1007/s11164-014-1562-4
A mild and efficient method for the conversion of aldehydes into nitriles and thiols into disulfides using an ionic liquid oxidant
R. Hosseinzadeh (2014)
10.1016/j.psychres.2012.01.009
Potential role of cortical 5-HT2A receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal
A. Benyamina (2012)
10.1007/978-1-59745-387-5
Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health
L. Baer (2010)
"Revised Clinical Institute Withdrawal Assessment for Alcohol Scale" als Prädiktor für die Schwere des Alkoholentzugs
Luise Weitzdörfer (2010)
10.1002/14651858.CD005063.pub3
Benzodiazepines for alcohol withdrawal.
L. Amato (2010)
10.1021/jm100762r
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.
F. Fleming (2010)
10.1007/978-1-59745-387-5_5
Rating scales for alcohol and nicotine addictions.
Julie D. Yeterian (2009)
10.1016/S1155-1968(09)46459-9
Traitement de l'alcoolodépendance
D. Mennecier (2009)
10.1016/J.EJPHAR.2007.09.025
Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
A. Benyamina (2008)
10.1111/J.1530-0277.2007.00345.X
Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
B. Pittman (2007)
10.1080/00952990701315046
Gamma-Hydroxybutyrate Reduces both Withdrawal Syndrome and Hypercortisolism in Severe Abstinent Alcoholics: An Open Study vs. Diazepam
F. Nava (2007)
10.1111/J.1527-3458.2004.TB00023.X
Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome.
M. Bourin (2004)
Semantic Scholar Logo Some data provided by SemanticScholar